IRIS Institutional Research Information System - OPENBS Open Archive UniBS

Tomasoni, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.004
EU - Europa 532
AS - Asia 336
OC - Oceania 4
SA - Sud America 3
Totale 1.879
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.000
HK - Hong Kong 212
DE - Germania 133
FI - Finlandia 110
IT - Italia 107
CN - Cina 92
IE - Irlanda 67
GB - Regno Unito 50
UA - Ucraina 28
SE - Svezia 12
IN - India 11
BE - Belgio 7
FR - Francia 7
JP - Giappone 6
TR - Turchia 5
CA - Canada 4
NL - Olanda 4
SG - Singapore 4
PH - Filippine 3
AU - Australia 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PL - Polonia 2
RU - Federazione Russa 2
VE - Venezuela 2
AT - Austria 1
BR - Brasile 1
ES - Italia 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 1.879
Salva come PNG Salva come JPEG
Città #
Hong Kong 211
Chandler 138
Ashburn 135
Fairfield 102
Helsinki 98
Princeton 75
New York 69
Beijing 67
Dublin 67
Frankfurt am Main 41
Woodbridge 40
Houston 36
Wilmington 34
Cambridge 32
Seattle 32
Jacksonville 26
Brescia 23
Ann Arbor 22
Milan 19
Shanghai 17
Washington 15
Kilburn 12
Lappeenranta 12
Los Angeles 11
London 8
Brussels 7
Pune 6
Strasbourg 6
Trieste 6
West Jordan 6
Curno 4
Rome 4
San Diego 4
Acton 3
Chiswick 3
Des Moines 3
Eindhoven 3
Falkenstein 3
Prescot 3
Quezon City 3
San Francisco 3
Singapore 3
Toronto 3
Bari 2
Bergamo 2
Berlin 2
Bernareggio 2
Changsha 2
Chennai 2
Chicago 2
Christchurch 2
Codigoro 2
Conegliano 2
Fujinomiya 2
Gavardo 2
Hamburg 2
Hounslow 2
Kitamachi 2
Kocaeli 2
Melbourne 2
Miami 2
Miranda 2
Montesilvano Marina 2
Nanjing 2
Olginate 2
Padova 2
Palermo 2
Pisogne 2
Rockville 2
Sandigliano 2
Sivas 2
Thrissur 2
Tokyo 2
Toscolano-Maderno 2
Venice 2
Verona 2
Warsaw 2
Alessandria 1
Almaty 1
Amsterdam 1
Augusta 1
Beavercreek 1
Bologna 1
Bristol 1
Brookline 1
Castegnato 1
Como 1
Fornovo San Giovanni 1
Genova 1
Greenwich 1
Gunzenhausen 1
Hagersten 1
Hangzhou 1
Madison Heights 1
Mumbai 1
New Bedfont 1
Ningbo 1
Norwalk 1
Oklahoma City 1
Perugia 1
Totale 1.506
Salva come PNG Salva come JPEG
Nome #
August 2020 at a glance: focus on neurohormonal antagonists and electrolytes 99
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 74
Review: Evidence-Based Management of Acute Heart Failure 65
Highlights in heart failure 63
Acute heart failure: More questions than answers 60
Clinical characteristics and outcome of acute heart failure patients with mid-range ejection fraction. 58
In-hospital and long-term mortality for acute heart failure: analysis at the time of admission to the emergency department 54
COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease 49
Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study 47
September 2020 at a glance: focus on heart failure with preserved ejection fraction and medical therapy 37
July 2020 at a glance: focus on imaging and cardiomyopathies 36
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 35
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 34
Direct Oral Anticoagulants for the Treatment of Left Ventricular Thrombus-A New Indication? A Meta-summary of Case Reports. 33
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 32
Heart failure in the last year: progress and perspective 28
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 28
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 27
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 27
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 26
Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta-blockers in patients hospitalized for acute heart failure 25
Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score 25
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversy 25
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 24
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 23
March 2023 at a glance: pathophysiology, medical therapy and devices 21
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 21
Prognostic significance of serum potassium in patients hospitalized for acute heart failure 20
[Empagliflozin and heart failure: the EMPEROR-Reduced trial] 20
Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction 20
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 20
August 2021 at a glance: focus on cardiomyopathies, medical treatment and devices 20
April 2022 at a glance: focus on prevention, acute heart failure and heart failure with preserved ejection fraction 19
Updates in heart failure: sodium glucose co-transporter 2 inhibitors and beyond - major changes are coming 19
The prognostic value of serial troponin measurements in patients admitted for COVID-19 19
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 19
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 18
August 2022 at a glance: focus on heart failure with preserved ejection fraction and cardiac amyloidosis 18
[Transcatheter devices for chronic heart failure: state of the art] 18
[Sodium-glucose cotransporter 2 inhibitors and heart failure with preserved ejection fraction: the EMPEROR-Preserved and DELIVER studies] 17
Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration 17
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 16
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction 16
Myocardial Involvement in COVID-19: an Interaction Between Comorbidities and Heart Failure with Preserved Ejection Fraction. A Further Indication of the Role of Inflammation 16
Coronavirus disease 2019 and cardiovascular disease: what we have learnt during the last 2 years 15
January 2023 at a glance: focus on acute heart failure and medical therapy 15
A year in heart failure: an update of recent findings 15
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines 14
Value of the HFA-PEFF and H2 FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 14
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 14
Evolution of tricuspid regurgitation after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation and its impact on mortality 14
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae 14
Impact and predictors of device-related thrombus after percutaneous left atrial appendage closure 14
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 13
Sacubitril/valsartan in real-life European patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis 13
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 12
October 2022 at a glance: focus on clinical trials 12
Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry 12
Prognostic value of right ventricular longitudinal strain in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair 11
April 2023 at a glance: focus on diagnosis and comorbidities 11
Ischemic Etiology in Advanced Heart Failure: Insight from the HELP-HF Registry 11
Impact of ischaemic aetiology on the efficacy of intravenous ferric carboxymaltose in patients with iron deficiency and acute heart failure: insights from the AFFIRM-AHF trial 10
Obesity, heart failure with preserved ejection fraction, and the role of glucagon-like peptide-1 receptor agonists 10
December 2020 at a glance: focus on COVID-19, comorbidities and palliative care 9
Heart failure: an update from the last years and a look at the near future 9
July 2022 at a glance: focus on prognosis, devices and valvular heart disease 9
November 2020 at a glance: focus on comorbidities and medical treatment 9
June 2023 at a glance: focus on worsening heart failure, heart failure with preserved ejection fraction and valvular heart disease 9
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 9
Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis 9
Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials 8
Uptitrating Treatment After Heart Failure Hospitalization Across the Spectrum of Left Ventricular Ejection Fraction 8
January 2022 at a glance: time for the new ESC guidelines on heart failure 7
January 2021 at a glance: focus on sex differences, acute heart failure and exercise capacity 7
Addressing comorbidities in heart failure: When feeling better and living longer go in the same direction 7
Outcome and Morphofunctional Changes on Cardiac Magnetic Resonance in Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination 7
June 2022 at a glance: prevention, outcomes and treatment 7
June 2021 at a glance: focus on epidemiology, biomarkers and medical treatment 7
July 2021 at a glance: focus on blood volume distribution, haemodynamics and adherence to therapy 7
May 2023 at a glance: focus on pathophysiology, comorbidities and devices 6
March 2022 at a glance: focus on medical therapy, prevention and comorbidities 6
Coronary artery disease: novel insights in a long-standing disease 6
November 2021 at a glance: focus on prevention, comorbidities, cardiogenic shock and novel devices 6
September 2022 at a glance 6
NT-proBNP and high-intensity care for acute heart failure: the STRONG-HF trial 6
December 2021 at a glance: focus on medical treatment, valvular heart disease and prognostic models 6
Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis 6
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 6
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology 6
Sex-specific analysis of the rapid up-titration of guideline-directed medical therapies after a hospitalization for acute heart failure: Insights from the STRONG-HF trial 6
February 2023 at a glance: focus on pathophysiology and treatment 6
Device-based percutaneous treatments to decompress the left atrium in heart failure with preserved ejection fraction 6
February 2022 at a glance: focus on pathophysiology and acute heart failure 6
Detailed Assessment of the "I Need Help" Criteria in Patients With Heart Failure: Insights From the HELP-HF Registry 5
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 5
Sodium-glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction 5
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 5
Role of ejection fraction in patients at risk for advanced heart failure: insights from the HELP-HF registry 5
November 2022 at a glance: focus on epidemiology, prognosis and comorbidities 5
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 5
Totale 1.879
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.123
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202027 3 0 0 0 0 1 0 3 1 8 5 6
2020/2021340 12 13 13 23 8 20 89 68 20 38 21 15
2021/2022202 4 41 4 6 8 6 8 10 14 10 18 73
2022/2023486 59 36 8 18 36 137 7 32 73 15 31 34
2023/2024902 59 13 106 90 74 136 82 23 278 38 3 0
Totale 1.967